Co-crystal strucutre of PD-L1 with low molecular weight inhibitor

Co-crystal strucutre of PD-L1 with low molecular weight inhibitor Descriptor: 5-[[5-[[2-[bis(fluoranyl)methyl]-3-(2,3-dihydro-1,4-benzodioxin-6-yl)phenyl]methoxy]-2-[(2-hydroxyethylamino)methyl]phenoxy]methyl]pyridine-3-carbonitrile, Programmed cell death 1 ligand 1, SULFATE ION Authors: Plewka, J, Magiera-Mularz, K, Zhang, W. Deposit date: 2024-03-25 Release date: 2024-07-24 Last modified: 2024-10-23 Method: X-RAY DIFFRACTION (2.7 Å) Cite: Design, synthesis, and evaluation of antitumor activity of 2-arylmethoxy-4-(2-fluoromethyl-biphenyl-3-ylmethoxy) benzylamine derivatives as PD-1/PD-l1 inhibitors. Eur.J.Med.Chem., 276, 2024